Top in hem/onc: Colorectal cancer screening, liver metastases
Click Here to Manage Email Alerts
The U.S. Preventive Services Task Force released a draft recommendation expanding colorectal cancer screening to adults aged 45 years. It was the top story in hematology/oncology last week.
Another top story was about data that showed Black patients were less likely to undergo treatment for colorectal liver metastases than patients of other races and ethnicities.
Read these and more top stories in hematology/oncology below:
USPSTF expands colorectal cancer screening recommendation to include adults aged 45 years
All adults should begin to get screened for colorectal cancer at age 45 years, according to a draft recommendation by the U.S. Preventive Services Task Force. Read more.
Black patients less likely to undergo treatment for colorectal liver metastases
Black patients with colorectal liver metastases had a lower likelihood of undergoing chemotherapy or resection and had shorter survival compared with their counterparts of other races and ethnicities, according to a research letter in JAMA Network Open. Read more.
COVID-19, manufacturing challenges limit cell and gene therapy progress, FDA official says
Progress in the field of gene and cell therapy continues with rapid development despite the negative impact of COVID-19 on research into novel treatments, according to the director of FDA’s Center for Biologics Evaluation and Research. Read more.
Stereotactic radiosurgery may be new standard of care for four or more brain metastases
Stereotactic radiosurgery conferred equivalent overall survival as whole-brain radiation but with less cognitive decline in patients with four or more nonmelanoma brain metastases, according to study results presented at the virtual ASTRO Annual Meeting. Read more.
From Resident to Patient: A Surgeon Shares His Journey with Lung Cancer
As a resident, Dan Tran, DDS, experienced the unthinkable — he was diagnosed with stage IV lung cancer. Tran shares his story — from diagnosis to undergoing treatment and finishing residency amidst the COVID-19 pandemic. Read more.